Tablets

NAD+ is a crucial coenzyme for cellular energy metabolism and DNA repair—declining with age, impairing mitochondrial function and resilience. Direct NAD+ supplementation is ineffective due to poor oral bioavailability; NMN and NR serve as precursors that elevate intracellular NAD+. Key industry distinction: separate healthy aging support (evidenced) from lifespan extension (unproven). While NMN/NR help maintain metabolic efficiency and cellular repair, no conclusive human clinical evidence confirms they extend maximum lifespan. Overblown "age reversal" claims face regulatory scrutiny. Responsible brands should adopt phrasing around healthy aging, cellular energy, and DNA maintenance—not unsubstantiated longevity promises.

Live probiotics face inherent flaws—viability loss from heat, stomach acid, and bile, requiring cold‑chain logistics and uncertain label accuracy. Postbiotics—metabolites and bioactive compounds from probiotic fermentation—retain core benefits (microbiota modulation, gut barrier support, immune balance) without live cells. Emerging research extends benefits to sleep and athletic performance, positioning postbiotics within the gut‑brain‑emotion‑sleep framework. Their key advantage: exceptional stability, tolerating heat and pH variations. Formulators can integrate them into gummies, beverages, bars, powders, and capsules. No refrigeration needed, no viability risk. Postbiotics are the next major frontier in global gut health.

Modern screen time (7.8 hours daily) drives global eye health concerns. Lutein and zeaxanthin—carotenoids concentrated in the retina—protect via blue-light filtration (absorbing 400-480nm) and antioxidant activity (neutralizing free radicals). Clinical evidence shows 6-20mg lutein with 1-4mg zeaxanthin increases macular pigment density, reducing eye strain and dryness. The global eye health supplement market reached $1.95B in 2024, projected to hit $2.94B by 2030. Choose 5:1 or 10:2 ratios, bioavailable formulations, and third-party certification.